Literature DB >> 6426972

Partial characterization of the putative rat interleukin 2 receptor.

H Osawa, T Diamantstein.   

Abstract

T lymphoblasts of rat origin were (a) surface labeled with 125I and (b) internally labeled with 3H-marked sugars. Cell lysates were purified by immunoabsorption using the putative anti-rat interleukin 2 (IL2) receptor monoclonal antibody ART18 . The purified material was subjected to sodium dodecyl sulfate polyacrylamide gel electrophoretic analysis. Two specific membrane components were detected: a 50-kDa major and a 36-kDa minor component in reducing and a 45-kDA major and a 72-kDa minor component in nonreducing conditions, respectively. Both components were found to be susceptible to trypsinization and to neuraminidase treatment. 3H-labeled sugars were incorporated into the major component. The results indicate that the rat IL2 receptor is either a 50-kDa glycoprotein or a 36-kDa molecule, or that both components are part of the receptor molecule.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6426972     DOI: 10.1002/eji.1830140418

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  3 in total

1.  Monitoring of interleukin-2 receptor (IL-2R) expression in vivo and studies on an IL-2R-directed immunosuppressive therapy of active and adoptive adjuvant-induced arthritis in rats.

Authors:  K G Stünkel; P Theisen; A Mouzaki; T Diamantstein; H D Schlumberger
Journal:  Immunology       Date:  1988-08       Impact factor: 7.397

2.  Prolongation of rat pancreatic islet allograft survival by treatment of recipient rats with monoclonal anti-interleukin-2 receptor antibody and cyclosporin.

Authors:  H J Hahn; B Kuttler; A Dunger; I Klöting; S Lucke; H D Volk; R von Baehr; T Diamantstein
Journal:  Diabetologia       Date:  1987-01       Impact factor: 10.122

3.  Therapy with monoclonal antibody to interleukin 2 receptor spares suppressor T cells and prevents or reverses acute allograft rejection in rats.

Authors:  J W Kupiec-Weglinski; T Diamantstein; N L Tilney; T B Strom
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.